May 27, 2012 /
The MIRROR study is evaluating whether an investigational medication called ofatumumab affects the number of newly developing MS-related brain lesions and the relapse rate for patients with relapsing-remitting multiple sclerosis (RRMS).
Read and learn more of this study for those with RRMS.
..
Comments are appreciated. Note that All comments are moderated
If not yet receiving our weekly e-Newsletter – : REGISTER –
so that you can be kept up to date with MS News and Information
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
LIKE this BLOG? – Please click the LIKE button top left
so that you can be kept up to date with MS News and Information
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
LIKE this BLOG? – Please click the LIKE button top left
…………………………
Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews
Stay informed with MS news and information - Sign-up here
For MS patients, caregivers or clinicians, Care to chat about MS? Join Our online COMMUNITY CHAT
